DISCONTINUED OPERATIONS (TABLES)

12 Months Ended

Jun. 30, 2012

Notes to Financial Statements [Abstract]

Net Earnings from Discontinued Operations for the Pharmaceuticals and Coffee Businesses

Following is selected financial information included in net earnings from discontinued operations for the snacks and pharmaceuticals businesses:

		Net sales		Earnings from discontinued operations		Income tax expense			Gain on sale of discontinued operations		Income tax benefit/(expense) on sale			Net earnings from discontinued operations
Snacks	2012	$	1,440	$	266	$	(96	)	$	1,899	$	(482	)	$	1,587
	2011	1,455		322		(93		)	—		—			229
	2010	1,372		289		(84		)	—		—			205
Pharmaceuticals	2012	—		—		—			—		—			—
	2011	—		—		—			—		—			—
	2010	751		306		(101		)	2,632		(1,047		)	1,790
Total	2012	1,440		266		(96		)	1,899		(482		)	1,587
	2011	1,455		322		(93		)	—		—			229
	2010	2,123		595		(185		)	2,632		(1,047		)	1,995

The net gain on the sale of the pharmaceuticals business for the year ended June 30, 2010, also includes an after-tax gain on the sale of the Actonel brand in Japan. This transaction occurred prior to the divestiture to Warner Chilcott.